{"gene":"HES1","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1994,"finding":"HES-1 is a bHLH transcriptional repressor that, when persistently expressed via retroviral transduction in neural precursor cells, prevents neuronal and glial differentiation and keeps cells in the ventricular/subventricular zone, establishing HES-1 as a negative regulator of neural differentiation.","method":"Retroviral transduction of HES-1 into mouse embryonic neural precursor cells in vivo and in vitro; immunostaining for neuronal/glial markers","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — clean gain-of-function in vivo with defined cellular phenotype, replicated across in vivo and in vitro settings","pmids":["7909512"],"is_preprint":false},{"year":1994,"finding":"The human HES1 gene (HRY) is encoded by four exons and maps to chromosome 3q28-q29; its predicted amino acid sequence differs from the rat homolog at only four positions, confirming orthology.","method":"Genomic cloning, sequencing, and fluorescence in situ hybridization (FISH)","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 1 — direct genomic characterization with chromosomal localization","pmids":["8020957"],"is_preprint":false},{"year":1999,"finding":"Hes1 is required cell-autonomously for the expansion of early T cell precursors at the CD4-CD8- double-negative stage in the thymus; Hes1-null fetal liver cells transferred into RAG2-null hosts fail to generate mature T cells due to defects in both TCR-independent and TCR-dependent thymocyte expansion.","method":"Hes1-null mouse genetics; fetal liver cell transfer into RAG2-null hosts; flow cytometric analysis of thymocyte populations","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — clean KO with cell-autonomous rescue experiment and defined cellular phenotype","pmids":["10323870"],"is_preprint":false},{"year":2000,"finding":"Hes1 promotes formation of Müller glia in the retina; retroviral overexpression of Hes1 drives glial marker expression in retinal progenitors, while misexpression of a dominant-negative Hes1 reduces glial number.","method":"Retroviral transduction of Hes1 and dominant-negative Hes1 in retinal progenitors; cotransfection reporter assays linking Rax to Hes1 regulatory regions","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 — reciprocal gain- and loss-of-function with defined cellular phenotype","pmids":["10839357"],"is_preprint":false},{"year":2000,"finding":"Hes6, a related bHLH protein, acts as an inhibitor of Hes1: Hes6 alone does not bind DNA but suppresses Hes1-mediated transcriptional repression and relieves Hes1 inhibition of Mash1-E47 heterodimers, thereby promoting neuronal differentiation. Mutation of the loop region of Hes1 and Hes6 shows the loop is functionally important for their distinct activities.","method":"Transcriptional reporter assays; retroviral misexpression in developing retina; domain swap mutagenesis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro transcriptional assays combined with mutagenesis and in vivo retroviral experiments","pmids":["10851137"],"is_preprint":false},{"year":2000,"finding":"Hes1 operates as a general negative regulator of endodermal endocrine differentiation; Hes1-deficient mice display severe pancreatic hypoplasia due to accelerated differentiation of glucagon-expressing post-mitotic endocrine cells, with upregulation of multiple bHLH components driving precocious and excessive endocrine differentiation in stomach and gut.","method":"Hes1 knockout mouse analysis; histology and marker expression in pancreas, stomach and gut","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 — clean KO with multiple tissue phenotypes and molecular marker analysis, highly cited","pmids":["10615124"],"is_preprint":false},{"year":2000,"finding":"HES-1 represses transcription through its helix 3-helix 4 (H3/4) domain independently of its WRPW corepressor-recruitment motif; the H3/4 domain mediates DNA-binding-dependent transcriptional repression and is required for inhibition of NGF-induced differentiation, cell growth arrest, and direct repression of the p21 promoter in PC12 cells.","method":"Tetracycline-inducible expression of HES-1 domain mutants in PC12 cells; transcription reporter assays; BrdU incorporation; PCNA measurement","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis combined with in vitro transcription assays and cellular phenotype readouts","pmids":["10913198"],"is_preprint":false},{"year":2001,"finding":"Hes1 and Hes3 redundantly prevent premature differentiation of isthmic organizer cells; in Hes1/Hes3 double-null mice the midbrain and anterior hindbrain are missing because organizer cells prematurely differentiate into neurons and lose expression of Fgf8, Wnt1, and Pax2/5.","method":"Hes1/Hes3 double-knockout mouse genetics; in situ hybridization and immunostaining for organizer markers","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — double-KO epistasis with defined molecular pathway and phenotypic readouts","pmids":["11500373"],"is_preprint":false},{"year":2002,"finding":"Hes1 interaction with Groucho/TLE corepressors induces hyperphosphorylation of TLE proteins by protein kinase CK2, which promotes TLE association with chromatin and enhances transcriptional repression; pharmacological inhibition of CK2 reduces TLE hyperphosphorylation, chromatin association, and repression activity.","method":"Co-immunoprecipitation; in vitro kinase assay with purified CK2; chromatin fractionation; pharmacological CK2 inhibition; transcription reporter assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase reconstitution plus cell-based mechanistic experiments with orthogonal methods","pmids":["11756536"],"is_preprint":false},{"year":2002,"finding":"Hes-1 can act as either a transcriptional repressor or activator in a cell-type-specific manner: it represses the human acid alpha-glucosidase (GAA) promoter in HepG2 cells but activates the same element in human fibroblasts, as demonstrated by site-directed mutagenesis of the Hes-1 binding site and Hes-1 overexpression assays.","method":"Transfection reporter assays; site-directed mutagenesis; Hes-1 overexpression in fibroblasts vs. HepG2 cells","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1–2 — mutagenesis + reporter assays in two cell types, single lab","pmids":["11855828"],"is_preprint":false},{"year":2003,"finding":"Mathematical modeling informed by experimental data shows that oscillatory Hes1 mRNA and protein expression (period ~2 h) is driven by transcriptional time delays in a short negative autoregulatory feedback loop, without requiring additional pathway components.","method":"Mathematical/computational modeling using delay differential equations fitted to experimental Hes1 expression data","journal":"Current biology : CB","confidence":"Medium","confidence_rationale":"Tier 4 computational model, but informed by experimental data and highly cited foundational work","pmids":["12932324"],"is_preprint":false},{"year":2005,"finding":"Hes1 directly represses p27Kip1 transcription by binding to class C sites in the p27Kip1 promoter, thereby promoting progenitor cell proliferation; conditional Hes1 expression in HeLa cells reduces p27Kip1 mRNA and protein and increases growth rate, while Hes1-deficient mice show increased p27Kip1 transcripts in thymus, liver, and brain.","method":"Tetracycline-inducible Hes1 expression; promoter-reporter assays; ChIP/DNA binding; qRT-PCR; Hes1 knockout mouse analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 — direct promoter binding demonstrated with reporter assays and in vivo genetic confirmation","pmids":["15870295"],"is_preprint":false},{"year":2006,"finding":"Persistent and high-level Hes1 expression in boundary cells of the developing CNS constitutively represses Mash1, forming neuron-free boundaries that act as organizing centers; in Hes1/Hes3/Hes5 triple-null mice, proneural genes are ectopically expressed in boundaries causing ectopic neurogenesis and loss of organizing centers.","method":"Triple-null mouse genetics; retroviral Hes1 misexpression; in situ hybridization for Mash1 and proneural genes","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis in triple-KO plus complementary gain-of-function","pmids":["16728479"],"is_preprint":false},{"year":2006,"finding":"Hes1 directly represses p57 (Cdkn1c) in pancreatic progenitors to maintain their cell cycle progression and self-renewal; inactivation of Hes1 upregulates p57, causing cell cycle arrest and precocious differentiation, and p57/Hes1 double-null embryos show progenitor expansion without apoptosis.","method":"Hes1 and p57/Hes1 double-knockout mouse genetics; promoter-reporter assays; BrdU labeling; flow cytometry","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — double-KO epistasis with direct promoter regulation evidence","pmids":["16899237"],"is_preprint":false},{"year":2007,"finding":"Id proteins (Id1–3) physically interact with Hes1 protein and release Hes1 negative autoregulation, thereby sustaining Hes1 expression levels in early neural stem cells without interfering with Hes1's ability to regulate other target genes; loss of Id1/Id3 reduces Hes1 expression and leads to precocious neurogenesis.","method":"Co-immunoprecipitation; Id2 overexpression in chick hindbrain; Id1/Id3 double-KO mouse analysis; Id1-3 RNAi in chick embryos","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP, in vivo gain-of-function and loss-of-function with defined phenotypes","pmids":["17681138"],"is_preprint":false},{"year":2007,"finding":"Serum-induced STAT3 oscillations regulate Hes1 expression by controlling its protein half-life, and loss of Hes1 oscillations causes G1 phase retardation; STAT oscillations are driven by delayed negative feedback via SOCS3, and coupled STAT-Hes1 oscillations are required for efficient cell cycle progression.","method":"Live-cell reporter assays; luciferase oscillation measurement; siRNA knockdown of Hes1 and Stat3; cell cycle analysis by FACS","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (live reporters, siRNA, FACS) in single lab with mechanistic pathway dissection","pmids":["17592117"],"is_preprint":false},{"year":2007,"finding":"Hes1 co-expressed with Runx2 in osteoblasts increases Runx2 protein stability (half-life), augments Runx2-DNA complex formation at target sites, and accelerates osteoblast differentiation including upregulation of osteopontin and type I collagen.","method":"Co-expression and retroviral overexpression in osteoblasts; Western blot for protein levels; cycloheximide chase; ChIP; osteogenic marker gene expression","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — co-expression with protein stability assay and ChIP, single lab","pmids":["18162173"],"is_preprint":false},{"year":2008,"finding":"The glucocorticoid receptor (GR) directly represses Hes1 promoter activity by recruiting histone deacetylase (HDAC) activities to the Hes1 gene; liver-specific disruption of GR induces Hes1 expression and reduces hepatic steatosis, and genetic restoration of Hes1 in steatotic animals normalizes hepatic triglyceride levels.","method":"Liver-specific GR knockout mice; chromatin immunoprecipitation (ChIP) for GR and HDAC at Hes1 promoter; Hes1 adenoviral restoration; triglyceride measurements","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP demonstrating direct GR-HDAC recruitment to Hes1 promoter plus in vivo genetic rescue experiments","pmids":["18762022"],"is_preprint":false},{"year":2010,"finding":"Hes1, acting as a transcriptional repressor downstream of oncogenic Notch1, sustains IKK activation in T-ALL by directly repressing the deubiquitinase CYLD, a negative regulator of the IKK complex, thereby maintaining NF-κB pathway activation.","method":"Human T-ALL cell lines and animal models; ChIP for Hes1 at CYLD locus; CYLD re-expression rescue experiments; IKK inhibition in vivo","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 2 — ChIP of direct target plus genetic rescue experiments in human and animal models","pmids":["20832754"],"is_preprint":false},{"year":2010,"finding":"In embryonic stem cells, Hes1 expression oscillates with a period of ~3–5 h; sustained Hes1 expression inhibits Notch signaling rather than acting as its effector, causing ES cells to prefer the mesodermal over the neural fate by suppressing Notch.","method":"Live-cell fluorescence reporter for Hes1 oscillations in mouse ES cells; sustained Hes1 expression constructs; differentiation assays","journal":"Genes to cells : devoted to molecular & cellular mechanisms","confidence":"Medium","confidence_rationale":"Tier 2 — live reporter oscillation measurement combined with gain-of-function differentiation assays, single lab","pmids":["20545770"],"is_preprint":false},{"year":2010,"finding":"Hes1 inhibits cycling of hematopoietic progenitor cells in a DNA-binding-dependent manner, associated with upregulation of p21Cip1/Waf1; a mutant Hes1 lacking the DNA-binding domain fails to inhibit cell cycling, indicating that HES1's anti-proliferative effect in HSPCs requires direct DNA binding.","method":"Lentiviral transduction of wild-type and DNA-binding-domain-deleted Hes1 mutant in human CD34+ and mouse HSPCs; cell cycle analysis; in vivo repopulation assays","journal":"Stem cells (Dayton, Ohio)","confidence":"High","confidence_rationale":"Tier 2 — domain-deletion mutagenesis with in vitro and in vivo functional readouts","pmids":["16513761"],"is_preprint":false},{"year":2010,"finding":"The Notch target Hes1 binds the Gli1 first intron and represses Gli1 transcription (Hedgehog pathway), as shown by chromatin immunoprecipitation in GBM neurosphere lines; this cross-pathway repression may underlie resistance to Notch inhibition.","method":"Chromatin immunoprecipitation (ChIP) for Hes1 at Gli1 first intron; gamma-secretase inhibitor treatment; combined Notch + Hedgehog inhibitor assays","journal":"Clinical cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP demonstrating direct binding at Gli1 locus, single lab","pmids":["21169257"],"is_preprint":false},{"year":2011,"finding":"HES1 physically interacts with PARP1 in B-cell ALL; this interaction inhibits HES1 transcriptional function and induces PARP1 activation, self-ADP ribosylation, NAD+ consumption, ATP depletion, and AIF nuclear translocation, leading to apoptosis in a cell-type-specific manner.","method":"Co-immunoprecipitation of HES1 and PARP1; PARP1 activity assays; NAD+/ATP measurement; AIF translocation imaging; B-ALL vs. T-ALL comparison","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP with biochemical activity assays and mechanistic pathway dissection","pmids":["21224467"],"is_preprint":false},{"year":2012,"finding":"miR-9 directly binds the 3'-UTR of Hes1 mRNA (seed sequence complementarity confirmed), negatively regulates Hes1 protein levels, and is required for oscillatory Hes1 mRNA expression in neural stem cells; miR-9 knockdown inhibits Hes1 oscillations and blocks neuronal differentiation.","method":"Luciferase 3'-UTR reporter assays; miR-9 overexpression and knockdown in developing mouse brain; Hes1 protein and mRNA quantification; cell cycle analysis","journal":"Genes to cells : devoted to molecular & cellular mechanisms","confidence":"High","confidence_rationale":"Tier 2 — direct 3'-UTR interaction validated by reporter assay, combined with in vivo knockdown and oscillation analysis","pmids":["23134481"],"is_preprint":false},{"year":2015,"finding":"Deubiquitinases Usp27x, Usp22, and Usp51 directly deubiquitinate and stabilize Hes1 protein; Usp22 knockdown shortens Hes1 half-life and delays its oscillation, enhancing neuronal differentiation, while Usp27x mis-expression reduces neuronal differentiation.","method":"Hes1 immunoprecipitation from mouse ES cells with MS identification of interacting deubiquitinases; in vitro deubiquitination assays; cycloheximide chase; in vivo knockdown in developing mouse brain","journal":"The FEBS journal","confidence":"High","confidence_rationale":"Tier 1–2 — MS-based interactome, in vitro deubiquitination assay, and in vivo functional validation","pmids":["25846153"],"is_preprint":false},{"year":2015,"finding":"The transcription factor Hes1 directly represses PUMA/BBC3 (a proapoptotic BH3-only factor) in T-ALL, as demonstrated by ChIP; loss of Hes1 in T-ALL cells decreases survival, establishing HES1 as a critical mediator of NOTCH1-induced leukemogenesis through suppression of apoptosis.","method":"ChIP for HES1 at BBC3/PUMA locus; shRNA knockdown of HES1 in T-ALL cell lines and in vivo leukemia model; gene expression analysis","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — ChIP of direct target combined with in vitro and in vivo loss-of-function","pmids":["25784680"],"is_preprint":false},{"year":2015,"finding":"Insm1 binds the Hes1 promoter and represses Hes1 expression in pulmonary neuroendocrine cells; in Insm1-mutant mice, Hes1 is upregulated in neuroendocrine cells, blocking their terminal differentiation and interfering with Ascl1 maintenance.","method":"ChIP of Insm1 at Hes1 promoter; Insm1 knockout mouse analysis; immunostaining for Hes1 and Ascl1","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — direct ChIP binding at Hes1 promoter combined with in vivo KO phenotype","pmids":["26453796"],"is_preprint":false},{"year":2015,"finding":"OR1A1 activation induces cAMP/PKA/CREB signaling that upregulates HES-1, which then acts as a corepressor of PPARγ in hepatocytes, reducing triglyceride synthesis; this was shown by PKA inhibition, CREB phosphorylation assays, and OR1A1 loss-of-function.","method":"cAMP measurement; PKA activity assay; CREB phosphorylation Western blot; HES-1 siRNA knockdown; triglyceride and lipid accumulation assays","journal":"The international journal of biochemistry & cell biology","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological + siRNA dissection of pathway in single cell system, single lab","pmids":["25817041"],"is_preprint":false},{"year":2016,"finding":"Hes1 suppresses inflammatory gene expression (specifically CXCL1) by inhibiting recruitment of the positive transcription elongation complex P-TEFb, thereby preventing phosphorylation of RNA polymerase II at Ser2 and blocking productive elongation — a post-initiation mechanism of transcriptional repression.","method":"ChIP for P-TEFb, RNA Pol II Ser2P at CXCL1 locus; Hes1 conditional knockout macrophages; neutrophil recruitment assays in vivo; inflammatory arthritis model","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1–2 — mechanistic ChIP distinguishing elongation vs. initiation, combined with in vivo genetic KO","pmids":["27322654"],"is_preprint":false},{"year":2016,"finding":"CREB and Sirt1 antagonistically regulate Hes1 promoter activity in neural stem cells in response to glucose availability: low glucose promotes CREB binding and Hes1 expression/proliferation, while high glucose promotes Sirt1-dependent repression of the Hes1 promoter, leading to impaired proliferation.","method":"ChIP for CREB and Sirt1 at Hes1 promoter; CREB-deficient NSC cultures; Sirt1 pharmacological inhibition; glucose manipulation; proliferation assays","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — ChIP showing competitive binding plus loss-of-function with multiple orthogonal experiments","pmids":["26804914"],"is_preprint":false},{"year":2017,"finding":"HES1 directly binds the IGF2BP2 promoter and promotes IGF2BP2 expression; IGF2BP2 then recognizes and stabilizes m6A-modified GLUT1 mRNA, enhancing aerobic glycolysis in colorectal cancer cells.","method":"ChIP-PCR and dual-luciferase reporter for HES1 at IGF2BP2 promoter; m6A-RIP for GLUT1 mRNA; GLUT1 mRNA stability assays; HES1 knockdown/overexpression with metabolic readouts","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 2 — direct ChIP and reporter assay for promoter binding, RNA m6A pulldown for mechanistic follow-up, single lab","pmids":["37957183"],"is_preprint":false},{"year":2018,"finding":"HES1 binds the GADD34 promoter and represses its transcription; depletion of HES1 upregulates GADD34 during ER stress and increases cell death, identifying HES1 as a pro-survival repressor of the pro-apoptotic UPR gene GADD34.","method":"ChIP for HES1 at GADD34 promoter; HES1 siRNA knockdown in mouse and human cells; ER stress-induced cell death assays; GADD34 reporter assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — direct ChIP binding combined with loss-of-function in multiple cell types","pmids":["29491143"],"is_preprint":false},{"year":2019,"finding":"In quiescent adult neural stem cells, Hes1 levels remain oscillatory but with elevated peaks and troughs that continuously suppress Ascl1 expression; inactivation of Hes1 and related genes upregulates Ascl1 and increases neurogenesis, causing premature NSC depletion. Conversely, sustained Hes1 expression maintains quiescence by repressing Ascl1.","method":"Conditional Hes1 knockout mice; live-cell Hes1/Ascl1 reporters; quantitative imaging of oscillation dynamics in adult brain; Hes1/Hes3/Hes5 compound knockouts","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — live oscillation reporters combined with multiple genetic KO models with defined phenotypic readouts","pmids":["30862661"],"is_preprint":false},{"year":2019,"finding":"Hes1 drives oscillatory MyoD expression in activated muscle stem cells; ablation of the Hes1 oscillator disrupts stable MyoD oscillations, leading to sustained MyoD expression, increased differentiation, impaired muscle stem cell maintenance, and defective muscle growth and repair.","method":"Live-cell MyoD and Hes1 reporters in single fibers and primary cultures; Hes1 conditional knockout in muscle stem cells; postnatal muscle growth and regeneration assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — live oscillation reporters plus conditional KO with defined cellular and tissue phenotypes","pmids":["30862660"],"is_preprint":false},{"year":2019,"finding":"Hes1 positively regulates VEGF-C transcription through direct genomic occupancy (genome-wide ChIP-seq); VEGF-C then suppresses WDFY1 (a TLR signaling adaptor), attenuating type I IFN production; Hes1-deficient mice show heightened IFN signatures and enhanced antiviral resistance.","method":"Genome-wide Hes1 ChIP-seq; Hes1 conditional knockout mice; VEGF-C and WDFY1 expression analysis; encephalomyocarditis virus challenge; lupus nephritis model","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — genome-wide ChIP-seq for direct binding combined with in vivo KO and multiple functional readouts","pmids":["31015298"],"is_preprint":false},{"year":2019,"finding":"Hes1 modulates Shh responsiveness and ciliogenesis in hair follicle stem cells; epithelial Hes1 deletion impairs Smoothened ciliary accumulation upon Shh stimulation and delays anagen initiation; Smoothened agonist rescues anagen defects in Hes1-deficient follicles.","method":"Epithelial-specific Hes1 conditional knockout; ciliogenesis assays in primary keratinocytes; Smoothened ciliary localization imaging; Shh pathway reporter; depilation-induced hair regeneration assays","journal":"Stem cells (Dayton, Ohio)","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with pharmacological rescue and defined cellular mechanism","pmids":["31721388"],"is_preprint":false},{"year":2021,"finding":"RASSF1A acts as a scaffold for the SUMO-targeted E3 ubiquitin ligase SNURF/RNF4 to target HES1 for ubiquitin-mediated proteasomal degradation; RASSF1A directly uncouples the NOTCH-HES1 axis independently of the Hippo pathway.","method":"Co-immunoprecipitation of RASSF1A, SNURF/RNF4, and HES1; ubiquitination assays; proteasome inhibitor experiments; HES1 protein stability assays; tumor cell differentiation assays","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP with ubiquitination assays and protein stability experiments","pmids":["34897944"],"is_preprint":false},{"year":2022,"finding":"Notch/Hes1 signaling in myeloid cells downregulates lactate transporter MCT2 transcription, reducing intracellular lactate, which destabilizes the transcription factor c-Jun via FBW7 ubiquitin ligase-mediated degradation; lactate interacts with c-Jun to protect it from degradation, linking Notch-Hes1 to myeloid differentiation through lactate-c-Jun axis.","method":"LC-MS identification of c-Jun as intracellular lactate sensor; CRISPR-Cas9 gene disruption; ChIP for Hes1 at MCT2 locus; myeloid-specific Notch/RBP-J conditional activation; in vivo tumor models","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — MS-based interaction discovery, CRISPR validation, ChIP, and in vivo models with multiple orthogonal methods","pmids":["35263597"],"is_preprint":false},{"year":2022,"finding":"Hes1 directly binds the GABAB1 receptor (Gabbr1) promoter in medial prefrontal cortex neurons and represses its transcription; Notch1-Hes1 signaling thereby negatively regulates GABAB1 receptor expression and modulates neuronal activity and methamphetamine-induced behavioral sensitization.","method":"ChIP for Hes1 at GABAB1 promoter; genetic and pharmacological Notch1 manipulation in mouse mPFC; GABAB receptor pharmacology; locomotor sensitization behavioral assays","journal":"Molecular psychiatry","confidence":"High","confidence_rationale":"Tier 2 — direct ChIP at target promoter combined with bidirectional genetic/pharmacological manipulation and behavioral readouts","pmids":["35732696"],"is_preprint":false},{"year":2022,"finding":"HES1 transcriptionally activates immunoglobulin-binding protein 1 (IGBP1) expression, which in turn promotes PP6 (protein phosphatase 6) expression and inhibits its ubiquitination; L-menthol prevents proteasomal degradation of HES1, restoring this HES1-IGBP1-PP6 axis in keratinocytes and ameliorating psoriasis-like inflammation.","method":"Target identification with phenotypic screen; ChIP for HES1 at IGBP1 promoter; HES1 stability and proteasome inhibitor assays; IGBP1 and PP6 expression rescue experiments; imiquimod mouse model","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — ChIP at direct target promoter, protein stability assays, in vivo model with genetic and pharmacological manipulation","pmids":["36535970"],"is_preprint":false},{"year":2023,"finding":"Oscillatory Hes1 expression directly represses p21 (Cdkn1a) to promote neural stem cell proliferation, whereas sustained Hes1 overexpression paradoxically upregulates p21 by repressing Dusp7 (an ERK phosphatase), increasing p-ERK which induces p21; thus the dynamics of Hes1 expression differentially control NSC proliferation through p21.","method":"Conditional oscillatory vs. sustained Hes1 expression in mouse NSCs; p21 promoter reporter assays; Dusp7 expression analysis; p-ERK measurement; cell cycle and proliferation assays","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — controlled expression dynamics experiments with pathway dissection (Dusp7-ERK-p21 axis) and multiple cellular readouts","pmids":["37200191"],"is_preprint":false}],"current_model":"HES1 is a bHLH transcriptional repressor that functions downstream of Notch signaling to maintain progenitor/stem cell identity across multiple tissues by directly repressing proneural genes (Ascl1/Mash1) and cell cycle inhibitors (p27Kip1, p57, p21) through class C site DNA binding; its expression oscillates via a delayed negative autoregulatory feedback loop (facilitated by deubiquitinases Usp22/Usp27x/Usp51 and regulated by miR-9), with oscillatory versus sustained expression differentially controlling proliferation versus quiescence; it recruits Groucho/TLE corepressors (hyperphosphorylated by CK2), represses transcription elongation by blocking P-TEFb recruitment, directly targets immune genes (CYLD, CXCL1, GADD34, GABAB1, WDFY1/VEGF-C), and interacts with non-transcriptional partners (PARP1, PARP1, Runx2, SNURF/RNF4) to exert cell-type-specific pro- or anti-apoptotic effects."},"narrative":{"teleology":[{"year":1994,"claim":"Establishing HES1 as a neural differentiation repressor resolved the question of whether mammalian hairy/Enhancer-of-split homologs functionally inhibit neurogenesis, as shown by persistent HES1 expression blocking neuronal and glial differentiation in neural precursors.","evidence":"Retroviral HES1 transduction in mouse embryonic neural precursor cells in vivo and in vitro","pmids":["7909512"],"confidence":"High","gaps":["Mechanism of repression (DNA binding vs. protein sequestration) not yet distinguished","Identity of direct transcriptional targets unknown"]},{"year":2000,"claim":"Multi-tissue knockout analyses established HES1 as a general gatekeeper of progenitor cell differentiation across endoderm, retina, and CNS boundary regions, resolving whether its anti-differentiation function was neural-specific.","evidence":"Hes1-null and Hes1/Hes3 double-null mouse analyses in pancreas, gut, retina, and midbrain-hindbrain boundary; retroviral gain-of-function","pmids":["10615124","10839357","11500373","16728479"],"confidence":"High","gaps":["Direct transcriptional targets in each tissue not yet identified","Relationship between HES1 and cell cycle exit mechanisms unresolved"]},{"year":2000,"claim":"Domain dissection revealed that HES1 possesses two independent repression mechanisms — the WRPW/Groucho-dependent pathway and a helix 3/4 domain-dependent DNA-binding-dependent pathway — answering how HES1 could repress diverse targets including p21.","evidence":"Tetracycline-inducible HES1 domain mutants in PC12 cells with reporter assays and BrdU incorporation","pmids":["10913198"],"confidence":"High","gaps":["Identity of the helix 3/4 domain corepressor unknown","How the two repression modes are coordinated in vivo unresolved"]},{"year":2002,"claim":"Discovery that HES1 interaction with Groucho/TLE triggers CK2-mediated TLE hyperphosphorylation and chromatin association provided the first mechanistic link between HES1 binding and corepressor activation.","evidence":"Co-immunoprecipitation, in vitro CK2 kinase assay, chromatin fractionation, and pharmacological CK2 inhibition","pmids":["11756536"],"confidence":"High","gaps":["Whether CK2 phosphorylation is required in vivo not tested","How target specificity is achieved through TLE unknown"]},{"year":2003,"claim":"Mathematical modeling demonstrated that HES1's ~2-hour expression oscillations arise from delayed negative autoregulatory feedback without additional pathway components, framing HES1 as a biological clock.","evidence":"Delay differential equation modeling fitted to experimental Hes1 mRNA/protein dynamics","pmids":["12932324"],"confidence":"Medium","gaps":["Model not yet validated by perturbation of delay parameters in cells","Post-transcriptional regulators of oscillation period not identified"]},{"year":2005,"claim":"Identification of p27Kip1 and subsequently p57 as direct HES1 targets via class C site binding resolved how HES1 couples transcriptional repression to cell cycle control in progenitors.","evidence":"ChIP and reporter assays for p27Kip1 and p57 promoters; Hes1-KO and Hes1/p57-double-KO mouse phenotypes","pmids":["15870295","16899237"],"confidence":"High","gaps":["Whether HES1 represses all CKIs simultaneously or selectively in different tissues unclear","Chromatin state at CKI promoters under HES1 control not characterized"]},{"year":2007,"claim":"Discovery that Id proteins physically interact with HES1 to release its autorepression without blocking its other targets explained how neural stem cells sustain high HES1 levels while maintaining its repressive activity on differentiation genes.","evidence":"Co-immunoprecipitation; Id overexpression in chick hindbrain; Id1/Id3 double-KO mouse with precocious neurogenesis","pmids":["17681138"],"confidence":"High","gaps":["Structural basis of Id–HES1 interaction not resolved","Whether Id–HES1 modulation occurs in non-neural tissues unknown"]},{"year":2010,"claim":"Linking HES1 to NF-κB pathway maintenance in T-ALL through direct CYLD repression revealed a non-developmental oncogenic function, answering how Notch sustains IKK activation in leukemia.","evidence":"ChIP for HES1 at CYLD locus; CYLD re-expression rescue; T-ALL cell lines and animal models","pmids":["20832754"],"confidence":"High","gaps":["Whether CYLD repression by HES1 operates in normal T cells unknown","Additional immune targets of HES1 not yet surveyed genome-wide"]},{"year":2012,"claim":"Demonstration that miR-9 targets the HES1 3′-UTR and is required for Hes1 oscillations in neural stem cells established a post-transcriptional layer essential for the HES1 oscillatory clock.","evidence":"Luciferase 3′-UTR reporter; miR-9 knockdown blocking oscillations and neuronal differentiation in mouse brain","pmids":["23134481"],"confidence":"High","gaps":["Whether other miRNAs contribute to HES1 oscillation tuning not tested","How miR-9 itself oscillates relative to HES1 not fully resolved"]},{"year":2015,"claim":"Identification of Usp22, Usp27x, and Usp51 as deubiquitinases that stabilize HES1 protein revealed the ubiquitin-dependent turnover mechanism governing oscillation period and amplitude.","evidence":"MS-based interactome from mouse ES cells; in vitro deubiquitination assays; cycloheximide chase; in vivo knockdown in developing brain","pmids":["25846153"],"confidence":"High","gaps":["Identity of the E3 ubiquitin ligase(s) for HES1 turnover not yet defined at this point","Whether DUB activity itself oscillates unknown"]},{"year":2016,"claim":"Discovery that HES1 represses inflammatory genes by blocking P-TEFb recruitment and RNA Pol II Ser2 phosphorylation established a post-initiation repression mechanism distinct from classical promoter silencing.","evidence":"ChIP for P-TEFb and Pol II Ser2P at CXCL1 locus in Hes1 conditional KO macrophages; inflammatory arthritis model","pmids":["27322654"],"confidence":"High","gaps":["Whether elongation block is the primary mechanism at all HES1 targets unknown","Structural basis of P-TEFb exclusion by HES1 not resolved"]},{"year":2019,"claim":"Live imaging in adult neural and muscle stem cells demonstrated that oscillatory versus sustained HES1 expression differentially controls quiescence vs. differentiation, reframing HES1 dynamics as a fate-determining signal rather than a simple on/off switch.","evidence":"Live-cell Hes1/Ascl1/MyoD reporters; conditional Hes1 KO in adult NSCs and muscle stem cells; compound Hes1/3/5 knockouts","pmids":["30862661","30862660"],"confidence":"High","gaps":["How oscillation amplitude is sensed by downstream targets mechanistically unclear","Whether oscillation dynamics differ between tissue stem cell types not systematically compared"]},{"year":2021,"claim":"Identification of RASSF1A as a scaffold for SNURF/RNF4-mediated HES1 ubiquitination and degradation provided the missing E3 ligase pathway controlling HES1 protein turnover and explained how the Notch-HES1 axis can be uncoupled independently of Hippo.","evidence":"Co-immunoprecipitation of RASSF1A, SNURF/RNF4, and HES1; ubiquitination assays; proteasome inhibitor experiments","pmids":["34897944"],"confidence":"High","gaps":["Whether SNURF/RNF4 is the sole E3 for HES1 or acts redundantly with others unclear","In vivo significance in stem cell oscillation context not tested"]},{"year":2023,"claim":"Resolving the paradox of how oscillatory HES1 promotes proliferation while sustained HES1 induces quiescence, this study showed sustained HES1 represses Dusp7, elevating p-ERK which induces p21 — the opposite of oscillatory HES1's direct p21 repression — establishing dynamics-dependent pathway switching.","evidence":"Conditional oscillatory vs. sustained Hes1 expression in mouse NSCs; Dusp7 and p-ERK analysis; p21 reporter assays","pmids":["37200191"],"confidence":"High","gaps":["Whether Dusp7-ERK switching operates in non-neural stem cells unknown","How transcriptional dynamics are decoded at the chromatin level remains unresolved"]},{"year":null,"claim":"Key open questions include the structural basis for HES1's dual repression mechanisms (promoter silencing vs. elongation block), the full genome-wide catalog of direct targets across tissues, and how oscillation dynamics are decoded by downstream chromatin and signaling networks to produce binary fate outcomes.","evidence":"","pmids":[],"confidence":"High","gaps":["No crystal structure of HES1 in complex with corepressors or DNA","Systematic comparison of HES1 oscillation parameters across tissue stem cell types lacking","How HES1 dynamics-dependent pathway switching (e.g., Dusp7-ERK vs. direct p21 repression) is specified at the molecular level remains unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,6,9,11,13,18,25,28,30,31,38,39,40]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[6,11,13,20,21,25,28,31,34,38]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,6,8,11,28,34]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,18,19,37]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,3,5,7,12,32,33,35]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[11,13,15,20,40]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[2,28,34]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[22,25,31]}],"complexes":["HES1–Groucho/TLE corepressor complex"],"partners":["TLE1","PARP1","RUNX2","USP22","USP27X","RNF4","RASSF1A","ID1"],"other_free_text":[]},"mechanistic_narrative":"HES1 is a bHLH transcriptional repressor that functions as a central effector of Notch signaling to maintain progenitor and stem cell identity across neural, hematopoietic, endocrine, and muscle lineages by repressing proneural genes (Ascl1/Mash1) and cell cycle inhibitors (p27Kip1, p57, p21) [PMID:7909512, PMID:15870295, PMID:16899237, PMID:10615124]. HES1 recruits Groucho/TLE corepressors whose chromatin association is enhanced by CK2-mediated hyperphosphorylation, and it also represses transcription at the elongation step by blocking P-TEFb recruitment to target genes such as CXCL1 [PMID:11756536, PMID:27322654]. HES1 expression oscillates with an approximately 2-hour period driven by a delayed negative autoregulatory feedback loop tuned by miR-9-mediated mRNA decay and Usp22/Usp27x-mediated protein stabilization, and the distinction between oscillatory versus sustained HES1 expression differentially controls proliferation versus quiescence through opposing effects on p21 via the Dusp7-ERK axis [PMID:12932324, PMID:23134481, PMID:25846153, PMID:37200191]. Beyond developmental contexts, HES1 directly represses immune and stress-response genes including CYLD, GADD34, VEGF-C/WDFY1, and GABAB1, and its protein stability is regulated by RASSF1A-SNURF/RNF4-mediated ubiquitin-dependent degradation [PMID:20832754, PMID:29491143, PMID:31015298, PMID:34897944]."},"prefetch_data":{"uniprot":{"accession":"Q14469","full_name":"Transcription factor HES-1","aliases":["Class B basic helix-loop-helix protein 39","bHLHb39","Hairy and enhancer of split 1","Hairy homolog","Hairy-like protein","hHL"],"length_aa":280,"mass_kda":29.5,"function":"Transcriptional repressor of genes that require a bHLH protein for their transcription. May act as a negative regulator of myogenesis by inhibiting the functions of MYOD1 and ASH1. Binds DNA on N-box motifs: 5'-CACNAG-3' with high affinity and on E-box motifs: 5'-CANNTG-3' with low affinity (By similarity). May play a role in a functional FA core complex response to DNA cross-link damage, being required for the stability and nuclear localization of FA core complex proteins, as well as for FANCD2 monoubiquitination in response to DNA damage","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q14469/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HES1","classification":"Not Classified","n_dependent_lines":22,"n_total_lines":1208,"dependency_fraction":0.018211920529801324},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HES1","total_profiled":1310},"omim":[{"mim_id":"621173","title":"G PROTEIN-COUPLED RECEPTOR 146; GPR146","url":"https://www.omim.org/entry/621173"},{"mim_id":"621120","title":"DELTA-LIKE NONCANONICAL NOTCH LIGAND 2; DLK2","url":"https://www.omim.org/entry/621120"},{"mim_id":"618111","title":"ZINC FINGER PROTEIN 64; ZFP64","url":"https://www.omim.org/entry/618111"},{"mim_id":"618081","title":"IMMUNOGLOBULIN-LIKE DOMAIN-CONTAINING RECEPTOR 2; ILDR2","url":"https://www.omim.org/entry/618081"},{"mim_id":"617546","title":"HELT bHLH TRANSCRIPTION FACTOR; HELT","url":"https://www.omim.org/entry/617546"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/HES1"},"hgnc":{"alias_symbol":["FLJ20408","HES-1","bHLHb39"],"prev_symbol":["HRY"]},"alphafold":{"accession":"Q14469","domains":[{"cath_id":"4.10.280.10","chopping":"37-102","consensus_level":"medium","plddt":87.09,"start":37,"end":102},{"cath_id":"1.10.287","chopping":"103-154","consensus_level":"medium","plddt":89.8852,"start":103,"end":154}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q14469","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q14469-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q14469-F1-predicted_aligned_error_v6.png","plddt_mean":68.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HES1","jax_strain_url":"https://www.jax.org/strain/search?query=HES1"},"sequence":{"accession":"Q14469","fasta_url":"https://rest.uniprot.org/uniprotkb/Q14469.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q14469/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q14469"}},"corpus_meta":[{"pmid":"10615124","id":"PMC_10615124","title":"Control of endodermal endocrine development by Hes-1.","date":"2000","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10615124","citation_count":924,"is_preprint":false},{"pmid":"10839357","id":"PMC_10839357","title":"rax, Hes1, and notch1 promote the formation of Müller glia by postnatal retinal progenitor cells.","date":"2000","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/10839357","citation_count":421,"is_preprint":false},{"pmid":"12932324","id":"PMC_12932324","title":"Oscillatory expression of Hes1, p53, and NF-kappaB driven by transcriptional time delays.","date":"2003","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/12932324","citation_count":401,"is_preprint":false},{"pmid":"7909512","id":"PMC_7909512","title":"Persistent expression of helix-loop-helix factor HES-1 prevents mammalian neural differentiation in the central nervous system.","date":"1994","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/7909512","citation_count":339,"is_preprint":false},{"pmid":"20832754","id":"PMC_20832754","title":"The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia.","date":"2010","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/20832754","citation_count":237,"is_preprint":false},{"pmid":"10851137","id":"PMC_10851137","title":"The bHLH gene Hes6, an inhibitor of Hes1, promotes neuronal differentiation.","date":"2000","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10851137","citation_count":215,"is_preprint":false},{"pmid":"15870295","id":"PMC_15870295","title":"Hes1 directly controls cell proliferation through the transcriptional repression of p27Kip1.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15870295","citation_count":181,"is_preprint":false},{"pmid":"16728479","id":"PMC_16728479","title":"Persistent and high levels of Hes1 expression regulate boundary formation in the developing central nervous system.","date":"2006","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16728479","citation_count":177,"is_preprint":false},{"pmid":"10323870","id":"PMC_10323870","title":"The bHLH gene Hes1 is essential for expansion of early T cell precursors.","date":"1999","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/10323870","citation_count":177,"is_preprint":false},{"pmid":"17681138","id":"PMC_17681138","title":"Id sustains Hes1 expression to inhibit precocious neurogenesis by releasing negative autoregulation of Hes1.","date":"2007","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/17681138","citation_count":158,"is_preprint":false},{"pmid":"25781910","id":"PMC_25781910","title":"Hes1: a key role in stemness, metastasis and multidrug resistance.","date":"2015","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/25781910","citation_count":149,"is_preprint":false},{"pmid":"21169257","id":"PMC_21169257","title":"The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance.","date":"2010","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/21169257","citation_count":143,"is_preprint":false},{"pmid":"16899237","id":"PMC_16899237","title":"p57 and Hes1 coordinate cell cycle exit with self-renewal of pancreatic progenitors.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16899237","citation_count":130,"is_preprint":false},{"pmid":"30862661","id":"PMC_30862661","title":"High Hes1 expression and resultant Ascl1 suppression regulate quiescent vs. active neural stem cells in the adult mouse brain.","date":"2019","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/30862661","citation_count":130,"is_preprint":false},{"pmid":"10774739","id":"PMC_10774739","title":"The bHLH gene Hes1 regulates differentiation of multiple cell types.","date":"2000","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/10774739","citation_count":128,"is_preprint":false},{"pmid":"15060169","id":"PMC_15060169","title":"Dual roles for the Notch target gene Hes-1 in the differentiation of 3T3-L1 preadipocytes.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15060169","citation_count":128,"is_preprint":false},{"pmid":"12406868","id":"PMC_12406868","title":"HES-1 preserves purified hematopoietic stem cells ex vivo and accumulates side population cells in vivo.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12406868","citation_count":128,"is_preprint":false},{"pmid":"11500373","id":"PMC_11500373","title":"Hes1 and Hes3 regulate maintenance of the isthmic organizer and development of the mid/hindbrain.","date":"2001","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11500373","citation_count":127,"is_preprint":false},{"pmid":"18762022","id":"PMC_18762022","title":"The glucocorticoid receptor controls hepatic dyslipidemia through Hes1.","date":"2008","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/18762022","citation_count":120,"is_preprint":false},{"pmid":"17592117","id":"PMC_17592117","title":"Ultradian oscillations of Stat, Smad, and Hes1 expression in response to serum.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17592117","citation_count":105,"is_preprint":false},{"pmid":"16513761","id":"PMC_16513761","title":"HES1 inhibits cycling of hematopoietic progenitor cells via DNA binding.","date":"2006","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/16513761","citation_count":98,"is_preprint":false},{"pmid":"23134481","id":"PMC_23134481","title":"MicroRNA9 regulates neural stem cell differentiation by controlling Hes1 expression dynamics in the developing brain.","date":"2012","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/23134481","citation_count":95,"is_preprint":false},{"pmid":"16038893","id":"PMC_16038893","title":"Multiple requirements for Hes 1 during early eye formation.","date":"2005","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16038893","citation_count":93,"is_preprint":false},{"pmid":"10913198","id":"PMC_10913198","title":"HES-1 repression of differentiation and proliferation in PC12 cells: role for the helix 3-helix 4 domain in transcription repression.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10913198","citation_count":89,"is_preprint":false},{"pmid":"24492635","id":"PMC_24492635","title":"Hes1 is involved in the self-renewal and tumourigenicity of stem-like cancer cells in colon cancer.","date":"2014","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/24492635","citation_count":87,"is_preprint":false},{"pmid":"16120441","id":"PMC_16120441","title":"Regulation of the Notch target gene Hes-1 by TGFalpha induced Ras/MAPK signaling in human neuroblastoma cells.","date":"2005","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/16120441","citation_count":86,"is_preprint":false},{"pmid":"27322654","id":"PMC_27322654","title":"The transcriptional repressor Hes1 attenuates inflammation by regulating transcription elongation.","date":"2016","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27322654","citation_count":75,"is_preprint":false},{"pmid":"35263597","id":"PMC_35263597","title":"Notch-mediated lactate metabolism regulates MDSC development through the Hes1/MCT2/c-Jun axis.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/35263597","citation_count":75,"is_preprint":false},{"pmid":"28928869","id":"PMC_28928869","title":"HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter Proteins.","date":"2017","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28928869","citation_count":73,"is_preprint":false},{"pmid":"20545770","id":"PMC_20545770","title":"Hes1 regulates embryonic stem cell differentiation by suppressing Notch signaling.","date":"2010","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/20545770","citation_count":73,"is_preprint":false},{"pmid":"15465493","id":"PMC_15465493","title":"Expression of Hairy/Enhancer of Split genes, Hes1 and Hes5, during murine nephron morphogenesis.","date":"2004","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/15465493","citation_count":71,"is_preprint":false},{"pmid":"17367776","id":"PMC_17367776","title":"Hes1 is required for pituitary growth and melanotrope specification.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17367776","citation_count":70,"is_preprint":false},{"pmid":"27066918","id":"PMC_27066918","title":"HES1 in immunity and cancer.","date":"2016","source":"Cytokine & growth factor reviews","url":"https://pubmed.ncbi.nlm.nih.gov/27066918","citation_count":68,"is_preprint":false},{"pmid":"30862660","id":"PMC_30862660","title":"Oscillations of MyoD and Hes1 proteins regulate the maintenance of activated muscle stem cells.","date":"2019","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/30862660","citation_count":65,"is_preprint":false},{"pmid":"26804914","id":"PMC_26804914","title":"A CREB-Sirt1-Hes1 Circuitry Mediates Neural Stem Cell Response to Glucose Availability.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26804914","citation_count":60,"is_preprint":false},{"pmid":"27233500","id":"PMC_27233500","title":"Hes1: the maestro in neurogenesis.","date":"2016","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/27233500","citation_count":57,"is_preprint":false},{"pmid":"25817041","id":"PMC_25817041","title":"Activation of OR1A1 suppresses PPAR-γ expression by inducing HES-1 in cultured hepatocytes.","date":"2015","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/25817041","citation_count":53,"is_preprint":false},{"pmid":"11756536","id":"PMC_11756536","title":"Role for Hes1-induced phosphorylation in Groucho-mediated transcriptional repression.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11756536","citation_count":53,"is_preprint":false},{"pmid":"15033430","id":"PMC_15033430","title":"Roles of the bHLH gene Hes1 in retinal morphogenesis.","date":"2004","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/15033430","citation_count":53,"is_preprint":false},{"pmid":"21224467","id":"PMC_21224467","title":"Notch/HES1-mediated PARP1 activation: a cell type-specific mechanism for tumor suppression.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21224467","citation_count":53,"is_preprint":false},{"pmid":"16360401","id":"PMC_16360401","title":"Hairy Enhancer of Split-1 (HES-1), a Notch1 effector, inhibits the growth of carcinoid tumor cells.","date":"2005","source":"Surgery","url":"https://pubmed.ncbi.nlm.nih.gov/16360401","citation_count":50,"is_preprint":false},{"pmid":"25846153","id":"PMC_25846153","title":"Deubiquitinating enzymes regulate Hes1 stability and neuronal differentiation.","date":"2015","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/25846153","citation_count":49,"is_preprint":false},{"pmid":"21084301","id":"PMC_21084301","title":"HES1 (hairy and enhancer of split 1) is a determinant of bone mass.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21084301","citation_count":49,"is_preprint":false},{"pmid":"22411914","id":"PMC_22411914","title":"The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma.","date":"2012","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22411914","citation_count":48,"is_preprint":false},{"pmid":"18996108","id":"PMC_18996108","title":"Premature differentiation and aberrant movement of pituitary cells lacking both Hes1 and Prop1.","date":"2008","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18996108","citation_count":46,"is_preprint":false},{"pmid":"23871867","id":"PMC_23871867","title":"Hes1 and Hes5 regulate vascular remodeling and arterial specification of endothelial cells in brain vascular development.","date":"2013","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/23871867","citation_count":46,"is_preprint":false},{"pmid":"25624721","id":"PMC_25624721","title":"Hes1, an important gene for activation of hepatic stellate cells, is regulated by Notch1 and TGF-β/BMP signaling.","date":"2015","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/25624721","citation_count":45,"is_preprint":false},{"pmid":"26453796","id":"PMC_26453796","title":"Insm1 controls the differentiation of pulmonary neuroendocrine cells by repressing Hes1.","date":"2015","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/26453796","citation_count":44,"is_preprint":false},{"pmid":"26823491","id":"PMC_26823491","title":"Tigecycline Inhibits Glioma Growth by Regulating miRNA-199b-5p-HES1-AKT Pathway.","date":"2016","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/26823491","citation_count":41,"is_preprint":false},{"pmid":"31919081","id":"PMC_31919081","title":"HES1 and HES4 have non-redundant roles downstream of Notch during early human T-cell development.","date":"2021","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/31919081","citation_count":39,"is_preprint":false},{"pmid":"25784680","id":"PMC_25784680","title":"Therapeutic targeting of HES1 transcriptional programs in T-ALL.","date":"2015","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25784680","citation_count":39,"is_preprint":false},{"pmid":"18162173","id":"PMC_18162173","title":"Hes1 stimulates transcriptional activity of Runx2 by increasing protein stabilization during osteoblast differentiation.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18162173","citation_count":37,"is_preprint":false},{"pmid":"25216517","id":"PMC_25216517","title":"CPEB1 modulates differentiation of glioma stem cells via downregulation of HES1 and SIRT1 expression.","date":"2014","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25216517","citation_count":34,"is_preprint":false},{"pmid":"27537524","id":"PMC_27537524","title":"Notch-Hes-1 axis controls TLR7-mediated autophagic death of macrophage via induction of P62 in mice with lupus.","date":"2016","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/27537524","citation_count":34,"is_preprint":false},{"pmid":"31721388","id":"PMC_31721388","title":"Hes1 regulates anagen initiation and hair follicle regeneration through modulation of hedgehog signaling.","date":"2019","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/31721388","citation_count":34,"is_preprint":false},{"pmid":"32129527","id":"PMC_32129527","title":"Hes1 deficiency causes hematopoietic stem cell exhaustion.","date":"2020","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/32129527","citation_count":33,"is_preprint":false},{"pmid":"8020957","id":"PMC_8020957","title":"Genomic cloning and chromosomal localization of HRY, the human homolog to the Drosophila segmentation gene, hairy.","date":"1994","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8020957","citation_count":32,"is_preprint":false},{"pmid":"33544929","id":"PMC_33544929","title":"IL-6 and IL-8, secreted by myofibroblasts in the tumor microenvironment, activate HES1 to expand the cancer stem cell population in early colorectal tumor.","date":"2021","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/33544929","citation_count":32,"is_preprint":false},{"pmid":"32879444","id":"PMC_32879444","title":"MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity.","date":"2020","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/32879444","citation_count":31,"is_preprint":false},{"pmid":"28655839","id":"PMC_28655839","title":"The doublesex-related Dmrta2 safeguards neural progenitor maintenance involving transcriptional regulation of Hes1.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28655839","citation_count":31,"is_preprint":false},{"pmid":"37957183","id":"PMC_37957183","title":"HES1 promotes aerobic glycolysis and cancer progression of colorectal cancer via IGF2BP2-mediated GLUT1 m6A modification.","date":"2023","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/37957183","citation_count":30,"is_preprint":false},{"pmid":"37200191","id":"PMC_37200191","title":"Differential cell-cycle control by oscillatory versus sustained Hes1 expression via p21.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37200191","citation_count":29,"is_preprint":false},{"pmid":"31949107","id":"PMC_31949107","title":"Simultaneous Requirements for Hes1 in Retinal Neurogenesis and Optic Cup-Stalk Boundary Maintenance.","date":"2020","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31949107","citation_count":29,"is_preprint":false},{"pmid":"23686434","id":"PMC_23686434","title":"The role of dimerisation and nuclear transport in the Hes1 gene regulatory network.","date":"2013","source":"Bulletin of mathematical biology","url":"https://pubmed.ncbi.nlm.nih.gov/23686434","citation_count":29,"is_preprint":false},{"pmid":"27070866","id":"PMC_27070866","title":"Astragaloside IV protects cardiomyocytes from anoxia/reoxygenation injury by upregulating the expression of Hes1 protein.","date":"2015","source":"Canadian journal of physiology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27070866","citation_count":29,"is_preprint":false},{"pmid":"27639167","id":"PMC_27639167","title":"Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model.","date":"2016","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/27639167","citation_count":28,"is_preprint":false},{"pmid":"19688092","id":"PMC_19688092","title":"Hes1 potentiates T cell lymphomagenesis by up-regulating a subset of notch target genes.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19688092","citation_count":28,"is_preprint":false},{"pmid":"23509692","id":"PMC_23509692","title":"miR-1-mediated induction of cardiogenesis in mesenchymal stem cells via downregulation of Hes-1.","date":"2012","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/23509692","citation_count":27,"is_preprint":false},{"pmid":"26448192","id":"PMC_26448192","title":"Loss of Hes1 Differentiates Sessile Serrated Adenoma/Polyp From Hyperplastic Polyp.","date":"2016","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26448192","citation_count":26,"is_preprint":false},{"pmid":"25550047","id":"PMC_25550047","title":"Control of hair cell development by molecular pathways involving Atoh1, Hes1 and Hes5.","date":"2014","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/25550047","citation_count":25,"is_preprint":false},{"pmid":"21984123","id":"PMC_21984123","title":"Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma.","date":"2011","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/21984123","citation_count":25,"is_preprint":false},{"pmid":"30261495","id":"PMC_30261495","title":"microRNA-203 Modulates Wound Healing and Scar Formation via Suppressing Hes1 Expression in Epidermal Stem Cells.","date":"2018","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30261495","citation_count":25,"is_preprint":false},{"pmid":"23277114","id":"PMC_23277114","title":"The expression of NOTCH2, HES1 and SOX9 during mouse retinal development.","date":"2012","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/23277114","citation_count":24,"is_preprint":false},{"pmid":"25326132","id":"PMC_25326132","title":"Regulation of a Notch3-Hes1 pathway and protective effect by a tocopherol-omega alkanol chain derivative in muscle atrophy.","date":"2014","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/25326132","citation_count":24,"is_preprint":false},{"pmid":"36535970","id":"PMC_36535970","title":"Targeting the transcription factor HES1 by L-menthol restores protein phosphatase 6 in keratinocytes in models of psoriasis.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36535970","citation_count":24,"is_preprint":false},{"pmid":"11855828","id":"PMC_11855828","title":"Hes-1, a known transcriptional repressor, acts as a transcriptional activator for the human acid alpha-glucosidase gene in human fibroblast cells.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11855828","citation_count":24,"is_preprint":false},{"pmid":"35955415","id":"PMC_35955415","title":"Dysregulation of SIRT3 SUMOylation Confers AML Chemoresistance via Controlling HES1-Dependent Fatty Acid Oxidation.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35955415","citation_count":23,"is_preprint":false},{"pmid":"23207146","id":"PMC_23207146","title":"PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitis.","date":"2012","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/23207146","citation_count":22,"is_preprint":false},{"pmid":"39364745","id":"PMC_39364745","title":"Curcumin pretreatment attenuates myocardial ischemia/reperfusion injury by inhibiting ferroptosis, autophagy and apoptosis via HES1.","date":"2024","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39364745","citation_count":21,"is_preprint":false},{"pmid":"33622250","id":"PMC_33622250","title":"The NOTCH-HES-1 axis is involved in promoting Th22 cell differentiation.","date":"2021","source":"Cellular & molecular biology letters","url":"https://pubmed.ncbi.nlm.nih.gov/33622250","citation_count":20,"is_preprint":false},{"pmid":"20036862","id":"PMC_20036862","title":"Mouse microRNA-124 regulates the expression of Hes1 in P19 cells.","date":"2010","source":"Frontiers in bioscience (Elite edition)","url":"https://pubmed.ncbi.nlm.nih.gov/20036862","citation_count":20,"is_preprint":false},{"pmid":"29126793","id":"PMC_29126793","title":"Inhibition of Notch1/Hes1 signaling pathway improves radiosensitivity of colorectal cancer cells.","date":"2017","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29126793","citation_count":19,"is_preprint":false},{"pmid":"31015298","id":"PMC_31015298","title":"Hes1 attenuates type I IFN responses via VEGF-C and WDFY1.","date":"2019","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31015298","citation_count":19,"is_preprint":false},{"pmid":"21495212","id":"PMC_21495212","title":"Hes1/Hes5 gene inhibits differentiation via down-regulating Hash1 and promotes proliferation in cervical carcinoma cells.","date":"2010","source":"International journal of gynecological cancer : official journal of the International Gynecological Cancer Society","url":"https://pubmed.ncbi.nlm.nih.gov/21495212","citation_count":19,"is_preprint":false},{"pmid":"35732696","id":"PMC_35732696","title":"Medial prefrontal cortex Notch1 signalling mediates methamphetamine-induced psychosis via Hes1-dependent suppression of GABAB1 receptor expression.","date":"2022","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/35732696","citation_count":19,"is_preprint":false},{"pmid":"18636433","id":"PMC_18636433","title":"TGF-alpha induces upregulation and nuclear translocation of Hes1 in glioma cell.","date":"2008","source":"Cell biochemistry and function","url":"https://pubmed.ncbi.nlm.nih.gov/18636433","citation_count":19,"is_preprint":false},{"pmid":"34224859","id":"PMC_34224859","title":"Melatonin attenuates aortic oxidative stress injury and apoptosis in STZ-diabetes rats by Notch1/Hes1 pathway.","date":"2021","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/34224859","citation_count":18,"is_preprint":false},{"pmid":"20431921","id":"PMC_20431921","title":"Hes1 regulates formations of the hypophyseal pars tuberalis and the hypothalamus.","date":"2010","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/20431921","citation_count":18,"is_preprint":false},{"pmid":"31109645","id":"PMC_31109645","title":"SP promotes cell proliferation in esophageal squamous cell carcinoma through the NK1R/Hes1 axis.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31109645","citation_count":17,"is_preprint":false},{"pmid":"36321463","id":"PMC_36321463","title":"HES1 promoter activation dynamics reveal the plasticity, stemness and heterogeneity in neuroblastoma cancer stem cells.","date":"2022","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/36321463","citation_count":16,"is_preprint":false},{"pmid":"16322473","id":"PMC_16322473","title":"Overexpression of HES-1 is not sufficient to impose T-cell differentiation on human hematopoietic stem cells.","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/16322473","citation_count":16,"is_preprint":false},{"pmid":"31043492","id":"PMC_31043492","title":"HES1, two programs: promoting the quiescence and proliferation of adult neural stem cells.","date":"2019","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/31043492","citation_count":16,"is_preprint":false},{"pmid":"9790494","id":"PMC_9790494","title":"Genetic elements regulating HES-1 induction in Wnt-1-transformed PC12 cells.","date":"1998","source":"Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/9790494","citation_count":15,"is_preprint":false},{"pmid":"33067264","id":"PMC_33067264","title":"Hes1 Is Essential in Proliferating Ductal Cell-Mediated Development of Intrahepatic Cholangiocarcinoma.","date":"2020","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/33067264","citation_count":14,"is_preprint":false},{"pmid":"23489689","id":"PMC_23489689","title":"Jagged-1-HES-1 signaling inhibits the differentiation of TH17 cells via ROR gammat.","date":"2013","source":"Journal of biological regulators and homeostatic agents","url":"https://pubmed.ncbi.nlm.nih.gov/23489689","citation_count":14,"is_preprint":false},{"pmid":"30867133","id":"PMC_30867133","title":"Synchronization of Hes1 oscillations coordinates and refines condensation formation and patterning of the avian limb skeleton.","date":"2019","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/30867133","citation_count":14,"is_preprint":false},{"pmid":"28464285","id":"PMC_28464285","title":"Elimination of GPR146-mediated antiviral function through IRF3/HES1-signalling pathway.","date":"2017","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28464285","citation_count":14,"is_preprint":false},{"pmid":"34897944","id":"PMC_34897944","title":"RASSF1A disrupts the NOTCH signaling axis via SNURF/RNF4-mediated ubiquitination of HES1.","date":"2021","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/34897944","citation_count":14,"is_preprint":false},{"pmid":"29491143","id":"PMC_29491143","title":"Hairy and enhancer of split 1 (HES1) protects cells from endoplasmic reticulum stress-induced apoptosis through repression of .","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29491143","citation_count":14,"is_preprint":false},{"pmid":"34270850","id":"PMC_34270850","title":"ETV4 transcriptionally activates HES1 and promotes Stat3 phosphorylation to promote malignant behaviors of colon adenocarcinoma.","date":"2021","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/34270850","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46226,"output_tokens":9679,"usd":0.141931},"stage2":{"model":"claude-opus-4-6","input_tokens":13570,"output_tokens":3754,"usd":0.24255},"total_usd":0.384481,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"HES-1 is a bHLH transcriptional repressor that, when persistently expressed via retroviral transduction in neural precursor cells, prevents neuronal and glial differentiation and keeps cells in the ventricular/subventricular zone, establishing HES-1 as a negative regulator of neural differentiation.\",\n      \"method\": \"Retroviral transduction of HES-1 into mouse embryonic neural precursor cells in vivo and in vitro; immunostaining for neuronal/glial markers\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean gain-of-function in vivo with defined cellular phenotype, replicated across in vivo and in vitro settings\",\n      \"pmids\": [\"7909512\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The human HES1 gene (HRY) is encoded by four exons and maps to chromosome 3q28-q29; its predicted amino acid sequence differs from the rat homolog at only four positions, confirming orthology.\",\n      \"method\": \"Genomic cloning, sequencing, and fluorescence in situ hybridization (FISH)\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct genomic characterization with chromosomal localization\",\n      \"pmids\": [\"8020957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Hes1 is required cell-autonomously for the expansion of early T cell precursors at the CD4-CD8- double-negative stage in the thymus; Hes1-null fetal liver cells transferred into RAG2-null hosts fail to generate mature T cells due to defects in both TCR-independent and TCR-dependent thymocyte expansion.\",\n      \"method\": \"Hes1-null mouse genetics; fetal liver cell transfer into RAG2-null hosts; flow cytometric analysis of thymocyte populations\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with cell-autonomous rescue experiment and defined cellular phenotype\",\n      \"pmids\": [\"10323870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Hes1 promotes formation of Müller glia in the retina; retroviral overexpression of Hes1 drives glial marker expression in retinal progenitors, while misexpression of a dominant-negative Hes1 reduces glial number.\",\n      \"method\": \"Retroviral transduction of Hes1 and dominant-negative Hes1 in retinal progenitors; cotransfection reporter assays linking Rax to Hes1 regulatory regions\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain- and loss-of-function with defined cellular phenotype\",\n      \"pmids\": [\"10839357\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Hes6, a related bHLH protein, acts as an inhibitor of Hes1: Hes6 alone does not bind DNA but suppresses Hes1-mediated transcriptional repression and relieves Hes1 inhibition of Mash1-E47 heterodimers, thereby promoting neuronal differentiation. Mutation of the loop region of Hes1 and Hes6 shows the loop is functionally important for their distinct activities.\",\n      \"method\": \"Transcriptional reporter assays; retroviral misexpression in developing retina; domain swap mutagenesis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro transcriptional assays combined with mutagenesis and in vivo retroviral experiments\",\n      \"pmids\": [\"10851137\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Hes1 operates as a general negative regulator of endodermal endocrine differentiation; Hes1-deficient mice display severe pancreatic hypoplasia due to accelerated differentiation of glucagon-expressing post-mitotic endocrine cells, with upregulation of multiple bHLH components driving precocious and excessive endocrine differentiation in stomach and gut.\",\n      \"method\": \"Hes1 knockout mouse analysis; histology and marker expression in pancreas, stomach and gut\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with multiple tissue phenotypes and molecular marker analysis, highly cited\",\n      \"pmids\": [\"10615124\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"HES-1 represses transcription through its helix 3-helix 4 (H3/4) domain independently of its WRPW corepressor-recruitment motif; the H3/4 domain mediates DNA-binding-dependent transcriptional repression and is required for inhibition of NGF-induced differentiation, cell growth arrest, and direct repression of the p21 promoter in PC12 cells.\",\n      \"method\": \"Tetracycline-inducible expression of HES-1 domain mutants in PC12 cells; transcription reporter assays; BrdU incorporation; PCNA measurement\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with in vitro transcription assays and cellular phenotype readouts\",\n      \"pmids\": [\"10913198\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Hes1 and Hes3 redundantly prevent premature differentiation of isthmic organizer cells; in Hes1/Hes3 double-null mice the midbrain and anterior hindbrain are missing because organizer cells prematurely differentiate into neurons and lose expression of Fgf8, Wnt1, and Pax2/5.\",\n      \"method\": \"Hes1/Hes3 double-knockout mouse genetics; in situ hybridization and immunostaining for organizer markers\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — double-KO epistasis with defined molecular pathway and phenotypic readouts\",\n      \"pmids\": [\"11500373\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Hes1 interaction with Groucho/TLE corepressors induces hyperphosphorylation of TLE proteins by protein kinase CK2, which promotes TLE association with chromatin and enhances transcriptional repression; pharmacological inhibition of CK2 reduces TLE hyperphosphorylation, chromatin association, and repression activity.\",\n      \"method\": \"Co-immunoprecipitation; in vitro kinase assay with purified CK2; chromatin fractionation; pharmacological CK2 inhibition; transcription reporter assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase reconstitution plus cell-based mechanistic experiments with orthogonal methods\",\n      \"pmids\": [\"11756536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Hes-1 can act as either a transcriptional repressor or activator in a cell-type-specific manner: it represses the human acid alpha-glucosidase (GAA) promoter in HepG2 cells but activates the same element in human fibroblasts, as demonstrated by site-directed mutagenesis of the Hes-1 binding site and Hes-1 overexpression assays.\",\n      \"method\": \"Transfection reporter assays; site-directed mutagenesis; Hes-1 overexpression in fibroblasts vs. HepG2 cells\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis + reporter assays in two cell types, single lab\",\n      \"pmids\": [\"11855828\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Mathematical modeling informed by experimental data shows that oscillatory Hes1 mRNA and protein expression (period ~2 h) is driven by transcriptional time delays in a short negative autoregulatory feedback loop, without requiring additional pathway components.\",\n      \"method\": \"Mathematical/computational modeling using delay differential equations fitted to experimental Hes1 expression data\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 4 computational model, but informed by experimental data and highly cited foundational work\",\n      \"pmids\": [\"12932324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Hes1 directly represses p27Kip1 transcription by binding to class C sites in the p27Kip1 promoter, thereby promoting progenitor cell proliferation; conditional Hes1 expression in HeLa cells reduces p27Kip1 mRNA and protein and increases growth rate, while Hes1-deficient mice show increased p27Kip1 transcripts in thymus, liver, and brain.\",\n      \"method\": \"Tetracycline-inducible Hes1 expression; promoter-reporter assays; ChIP/DNA binding; qRT-PCR; Hes1 knockout mouse analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct promoter binding demonstrated with reporter assays and in vivo genetic confirmation\",\n      \"pmids\": [\"15870295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Persistent and high-level Hes1 expression in boundary cells of the developing CNS constitutively represses Mash1, forming neuron-free boundaries that act as organizing centers; in Hes1/Hes3/Hes5 triple-null mice, proneural genes are ectopically expressed in boundaries causing ectopic neurogenesis and loss of organizing centers.\",\n      \"method\": \"Triple-null mouse genetics; retroviral Hes1 misexpression; in situ hybridization for Mash1 and proneural genes\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in triple-KO plus complementary gain-of-function\",\n      \"pmids\": [\"16728479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Hes1 directly represses p57 (Cdkn1c) in pancreatic progenitors to maintain their cell cycle progression and self-renewal; inactivation of Hes1 upregulates p57, causing cell cycle arrest and precocious differentiation, and p57/Hes1 double-null embryos show progenitor expansion without apoptosis.\",\n      \"method\": \"Hes1 and p57/Hes1 double-knockout mouse genetics; promoter-reporter assays; BrdU labeling; flow cytometry\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — double-KO epistasis with direct promoter regulation evidence\",\n      \"pmids\": [\"16899237\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Id proteins (Id1–3) physically interact with Hes1 protein and release Hes1 negative autoregulation, thereby sustaining Hes1 expression levels in early neural stem cells without interfering with Hes1's ability to regulate other target genes; loss of Id1/Id3 reduces Hes1 expression and leads to precocious neurogenesis.\",\n      \"method\": \"Co-immunoprecipitation; Id2 overexpression in chick hindbrain; Id1/Id3 double-KO mouse analysis; Id1-3 RNAi in chick embryos\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP, in vivo gain-of-function and loss-of-function with defined phenotypes\",\n      \"pmids\": [\"17681138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Serum-induced STAT3 oscillations regulate Hes1 expression by controlling its protein half-life, and loss of Hes1 oscillations causes G1 phase retardation; STAT oscillations are driven by delayed negative feedback via SOCS3, and coupled STAT-Hes1 oscillations are required for efficient cell cycle progression.\",\n      \"method\": \"Live-cell reporter assays; luciferase oscillation measurement; siRNA knockdown of Hes1 and Stat3; cell cycle analysis by FACS\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (live reporters, siRNA, FACS) in single lab with mechanistic pathway dissection\",\n      \"pmids\": [\"17592117\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Hes1 co-expressed with Runx2 in osteoblasts increases Runx2 protein stability (half-life), augments Runx2-DNA complex formation at target sites, and accelerates osteoblast differentiation including upregulation of osteopontin and type I collagen.\",\n      \"method\": \"Co-expression and retroviral overexpression in osteoblasts; Western blot for protein levels; cycloheximide chase; ChIP; osteogenic marker gene expression\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-expression with protein stability assay and ChIP, single lab\",\n      \"pmids\": [\"18162173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The glucocorticoid receptor (GR) directly represses Hes1 promoter activity by recruiting histone deacetylase (HDAC) activities to the Hes1 gene; liver-specific disruption of GR induces Hes1 expression and reduces hepatic steatosis, and genetic restoration of Hes1 in steatotic animals normalizes hepatic triglyceride levels.\",\n      \"method\": \"Liver-specific GR knockout mice; chromatin immunoprecipitation (ChIP) for GR and HDAC at Hes1 promoter; Hes1 adenoviral restoration; triglyceride measurements\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP demonstrating direct GR-HDAC recruitment to Hes1 promoter plus in vivo genetic rescue experiments\",\n      \"pmids\": [\"18762022\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Hes1, acting as a transcriptional repressor downstream of oncogenic Notch1, sustains IKK activation in T-ALL by directly repressing the deubiquitinase CYLD, a negative regulator of the IKK complex, thereby maintaining NF-κB pathway activation.\",\n      \"method\": \"Human T-ALL cell lines and animal models; ChIP for Hes1 at CYLD locus; CYLD re-expression rescue experiments; IKK inhibition in vivo\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP of direct target plus genetic rescue experiments in human and animal models\",\n      \"pmids\": [\"20832754\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In embryonic stem cells, Hes1 expression oscillates with a period of ~3–5 h; sustained Hes1 expression inhibits Notch signaling rather than acting as its effector, causing ES cells to prefer the mesodermal over the neural fate by suppressing Notch.\",\n      \"method\": \"Live-cell fluorescence reporter for Hes1 oscillations in mouse ES cells; sustained Hes1 expression constructs; differentiation assays\",\n      \"journal\": \"Genes to cells : devoted to molecular & cellular mechanisms\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — live reporter oscillation measurement combined with gain-of-function differentiation assays, single lab\",\n      \"pmids\": [\"20545770\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Hes1 inhibits cycling of hematopoietic progenitor cells in a DNA-binding-dependent manner, associated with upregulation of p21Cip1/Waf1; a mutant Hes1 lacking the DNA-binding domain fails to inhibit cell cycling, indicating that HES1's anti-proliferative effect in HSPCs requires direct DNA binding.\",\n      \"method\": \"Lentiviral transduction of wild-type and DNA-binding-domain-deleted Hes1 mutant in human CD34+ and mouse HSPCs; cell cycle analysis; in vivo repopulation assays\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — domain-deletion mutagenesis with in vitro and in vivo functional readouts\",\n      \"pmids\": [\"16513761\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The Notch target Hes1 binds the Gli1 first intron and represses Gli1 transcription (Hedgehog pathway), as shown by chromatin immunoprecipitation in GBM neurosphere lines; this cross-pathway repression may underlie resistance to Notch inhibition.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) for Hes1 at Gli1 first intron; gamma-secretase inhibitor treatment; combined Notch + Hedgehog inhibitor assays\",\n      \"journal\": \"Clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP demonstrating direct binding at Gli1 locus, single lab\",\n      \"pmids\": [\"21169257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"HES1 physically interacts with PARP1 in B-cell ALL; this interaction inhibits HES1 transcriptional function and induces PARP1 activation, self-ADP ribosylation, NAD+ consumption, ATP depletion, and AIF nuclear translocation, leading to apoptosis in a cell-type-specific manner.\",\n      \"method\": \"Co-immunoprecipitation of HES1 and PARP1; PARP1 activity assays; NAD+/ATP measurement; AIF translocation imaging; B-ALL vs. T-ALL comparison\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP with biochemical activity assays and mechanistic pathway dissection\",\n      \"pmids\": [\"21224467\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"miR-9 directly binds the 3'-UTR of Hes1 mRNA (seed sequence complementarity confirmed), negatively regulates Hes1 protein levels, and is required for oscillatory Hes1 mRNA expression in neural stem cells; miR-9 knockdown inhibits Hes1 oscillations and blocks neuronal differentiation.\",\n      \"method\": \"Luciferase 3'-UTR reporter assays; miR-9 overexpression and knockdown in developing mouse brain; Hes1 protein and mRNA quantification; cell cycle analysis\",\n      \"journal\": \"Genes to cells : devoted to molecular & cellular mechanisms\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct 3'-UTR interaction validated by reporter assay, combined with in vivo knockdown and oscillation analysis\",\n      \"pmids\": [\"23134481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Deubiquitinases Usp27x, Usp22, and Usp51 directly deubiquitinate and stabilize Hes1 protein; Usp22 knockdown shortens Hes1 half-life and delays its oscillation, enhancing neuronal differentiation, while Usp27x mis-expression reduces neuronal differentiation.\",\n      \"method\": \"Hes1 immunoprecipitation from mouse ES cells with MS identification of interacting deubiquitinases; in vitro deubiquitination assays; cycloheximide chase; in vivo knockdown in developing mouse brain\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — MS-based interactome, in vitro deubiquitination assay, and in vivo functional validation\",\n      \"pmids\": [\"25846153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The transcription factor Hes1 directly represses PUMA/BBC3 (a proapoptotic BH3-only factor) in T-ALL, as demonstrated by ChIP; loss of Hes1 in T-ALL cells decreases survival, establishing HES1 as a critical mediator of NOTCH1-induced leukemogenesis through suppression of apoptosis.\",\n      \"method\": \"ChIP for HES1 at BBC3/PUMA locus; shRNA knockdown of HES1 in T-ALL cell lines and in vivo leukemia model; gene expression analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP of direct target combined with in vitro and in vivo loss-of-function\",\n      \"pmids\": [\"25784680\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Insm1 binds the Hes1 promoter and represses Hes1 expression in pulmonary neuroendocrine cells; in Insm1-mutant mice, Hes1 is upregulated in neuroendocrine cells, blocking their terminal differentiation and interfering with Ascl1 maintenance.\",\n      \"method\": \"ChIP of Insm1 at Hes1 promoter; Insm1 knockout mouse analysis; immunostaining for Hes1 and Ascl1\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct ChIP binding at Hes1 promoter combined with in vivo KO phenotype\",\n      \"pmids\": [\"26453796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"OR1A1 activation induces cAMP/PKA/CREB signaling that upregulates HES-1, which then acts as a corepressor of PPARγ in hepatocytes, reducing triglyceride synthesis; this was shown by PKA inhibition, CREB phosphorylation assays, and OR1A1 loss-of-function.\",\n      \"method\": \"cAMP measurement; PKA activity assay; CREB phosphorylation Western blot; HES-1 siRNA knockdown; triglyceride and lipid accumulation assays\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological + siRNA dissection of pathway in single cell system, single lab\",\n      \"pmids\": [\"25817041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Hes1 suppresses inflammatory gene expression (specifically CXCL1) by inhibiting recruitment of the positive transcription elongation complex P-TEFb, thereby preventing phosphorylation of RNA polymerase II at Ser2 and blocking productive elongation — a post-initiation mechanism of transcriptional repression.\",\n      \"method\": \"ChIP for P-TEFb, RNA Pol II Ser2P at CXCL1 locus; Hes1 conditional knockout macrophages; neutrophil recruitment assays in vivo; inflammatory arthritis model\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mechanistic ChIP distinguishing elongation vs. initiation, combined with in vivo genetic KO\",\n      \"pmids\": [\"27322654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CREB and Sirt1 antagonistically regulate Hes1 promoter activity in neural stem cells in response to glucose availability: low glucose promotes CREB binding and Hes1 expression/proliferation, while high glucose promotes Sirt1-dependent repression of the Hes1 promoter, leading to impaired proliferation.\",\n      \"method\": \"ChIP for CREB and Sirt1 at Hes1 promoter; CREB-deficient NSC cultures; Sirt1 pharmacological inhibition; glucose manipulation; proliferation assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP showing competitive binding plus loss-of-function with multiple orthogonal experiments\",\n      \"pmids\": [\"26804914\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"HES1 directly binds the IGF2BP2 promoter and promotes IGF2BP2 expression; IGF2BP2 then recognizes and stabilizes m6A-modified GLUT1 mRNA, enhancing aerobic glycolysis in colorectal cancer cells.\",\n      \"method\": \"ChIP-PCR and dual-luciferase reporter for HES1 at IGF2BP2 promoter; m6A-RIP for GLUT1 mRNA; GLUT1 mRNA stability assays; HES1 knockdown/overexpression with metabolic readouts\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct ChIP and reporter assay for promoter binding, RNA m6A pulldown for mechanistic follow-up, single lab\",\n      \"pmids\": [\"37957183\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"HES1 binds the GADD34 promoter and represses its transcription; depletion of HES1 upregulates GADD34 during ER stress and increases cell death, identifying HES1 as a pro-survival repressor of the pro-apoptotic UPR gene GADD34.\",\n      \"method\": \"ChIP for HES1 at GADD34 promoter; HES1 siRNA knockdown in mouse and human cells; ER stress-induced cell death assays; GADD34 reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct ChIP binding combined with loss-of-function in multiple cell types\",\n      \"pmids\": [\"29491143\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In quiescent adult neural stem cells, Hes1 levels remain oscillatory but with elevated peaks and troughs that continuously suppress Ascl1 expression; inactivation of Hes1 and related genes upregulates Ascl1 and increases neurogenesis, causing premature NSC depletion. Conversely, sustained Hes1 expression maintains quiescence by repressing Ascl1.\",\n      \"method\": \"Conditional Hes1 knockout mice; live-cell Hes1/Ascl1 reporters; quantitative imaging of oscillation dynamics in adult brain; Hes1/Hes3/Hes5 compound knockouts\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — live oscillation reporters combined with multiple genetic KO models with defined phenotypic readouts\",\n      \"pmids\": [\"30862661\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Hes1 drives oscillatory MyoD expression in activated muscle stem cells; ablation of the Hes1 oscillator disrupts stable MyoD oscillations, leading to sustained MyoD expression, increased differentiation, impaired muscle stem cell maintenance, and defective muscle growth and repair.\",\n      \"method\": \"Live-cell MyoD and Hes1 reporters in single fibers and primary cultures; Hes1 conditional knockout in muscle stem cells; postnatal muscle growth and regeneration assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — live oscillation reporters plus conditional KO with defined cellular and tissue phenotypes\",\n      \"pmids\": [\"30862660\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Hes1 positively regulates VEGF-C transcription through direct genomic occupancy (genome-wide ChIP-seq); VEGF-C then suppresses WDFY1 (a TLR signaling adaptor), attenuating type I IFN production; Hes1-deficient mice show heightened IFN signatures and enhanced antiviral resistance.\",\n      \"method\": \"Genome-wide Hes1 ChIP-seq; Hes1 conditional knockout mice; VEGF-C and WDFY1 expression analysis; encephalomyocarditis virus challenge; lupus nephritis model\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide ChIP-seq for direct binding combined with in vivo KO and multiple functional readouts\",\n      \"pmids\": [\"31015298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Hes1 modulates Shh responsiveness and ciliogenesis in hair follicle stem cells; epithelial Hes1 deletion impairs Smoothened ciliary accumulation upon Shh stimulation and delays anagen initiation; Smoothened agonist rescues anagen defects in Hes1-deficient follicles.\",\n      \"method\": \"Epithelial-specific Hes1 conditional knockout; ciliogenesis assays in primary keratinocytes; Smoothened ciliary localization imaging; Shh pathway reporter; depilation-induced hair regeneration assays\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with pharmacological rescue and defined cellular mechanism\",\n      \"pmids\": [\"31721388\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RASSF1A acts as a scaffold for the SUMO-targeted E3 ubiquitin ligase SNURF/RNF4 to target HES1 for ubiquitin-mediated proteasomal degradation; RASSF1A directly uncouples the NOTCH-HES1 axis independently of the Hippo pathway.\",\n      \"method\": \"Co-immunoprecipitation of RASSF1A, SNURF/RNF4, and HES1; ubiquitination assays; proteasome inhibitor experiments; HES1 protein stability assays; tumor cell differentiation assays\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP with ubiquitination assays and protein stability experiments\",\n      \"pmids\": [\"34897944\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Notch/Hes1 signaling in myeloid cells downregulates lactate transporter MCT2 transcription, reducing intracellular lactate, which destabilizes the transcription factor c-Jun via FBW7 ubiquitin ligase-mediated degradation; lactate interacts with c-Jun to protect it from degradation, linking Notch-Hes1 to myeloid differentiation through lactate-c-Jun axis.\",\n      \"method\": \"LC-MS identification of c-Jun as intracellular lactate sensor; CRISPR-Cas9 gene disruption; ChIP for Hes1 at MCT2 locus; myeloid-specific Notch/RBP-J conditional activation; in vivo tumor models\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — MS-based interaction discovery, CRISPR validation, ChIP, and in vivo models with multiple orthogonal methods\",\n      \"pmids\": [\"35263597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Hes1 directly binds the GABAB1 receptor (Gabbr1) promoter in medial prefrontal cortex neurons and represses its transcription; Notch1-Hes1 signaling thereby negatively regulates GABAB1 receptor expression and modulates neuronal activity and methamphetamine-induced behavioral sensitization.\",\n      \"method\": \"ChIP for Hes1 at GABAB1 promoter; genetic and pharmacological Notch1 manipulation in mouse mPFC; GABAB receptor pharmacology; locomotor sensitization behavioral assays\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct ChIP at target promoter combined with bidirectional genetic/pharmacological manipulation and behavioral readouts\",\n      \"pmids\": [\"35732696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"HES1 transcriptionally activates immunoglobulin-binding protein 1 (IGBP1) expression, which in turn promotes PP6 (protein phosphatase 6) expression and inhibits its ubiquitination; L-menthol prevents proteasomal degradation of HES1, restoring this HES1-IGBP1-PP6 axis in keratinocytes and ameliorating psoriasis-like inflammation.\",\n      \"method\": \"Target identification with phenotypic screen; ChIP for HES1 at IGBP1 promoter; HES1 stability and proteasome inhibitor assays; IGBP1 and PP6 expression rescue experiments; imiquimod mouse model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP at direct target promoter, protein stability assays, in vivo model with genetic and pharmacological manipulation\",\n      \"pmids\": [\"36535970\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Oscillatory Hes1 expression directly represses p21 (Cdkn1a) to promote neural stem cell proliferation, whereas sustained Hes1 overexpression paradoxically upregulates p21 by repressing Dusp7 (an ERK phosphatase), increasing p-ERK which induces p21; thus the dynamics of Hes1 expression differentially control NSC proliferation through p21.\",\n      \"method\": \"Conditional oscillatory vs. sustained Hes1 expression in mouse NSCs; p21 promoter reporter assays; Dusp7 expression analysis; p-ERK measurement; cell cycle and proliferation assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — controlled expression dynamics experiments with pathway dissection (Dusp7-ERK-p21 axis) and multiple cellular readouts\",\n      \"pmids\": [\"37200191\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HES1 is a bHLH transcriptional repressor that functions downstream of Notch signaling to maintain progenitor/stem cell identity across multiple tissues by directly repressing proneural genes (Ascl1/Mash1) and cell cycle inhibitors (p27Kip1, p57, p21) through class C site DNA binding; its expression oscillates via a delayed negative autoregulatory feedback loop (facilitated by deubiquitinases Usp22/Usp27x/Usp51 and regulated by miR-9), with oscillatory versus sustained expression differentially controlling proliferation versus quiescence; it recruits Groucho/TLE corepressors (hyperphosphorylated by CK2), represses transcription elongation by blocking P-TEFb recruitment, directly targets immune genes (CYLD, CXCL1, GADD34, GABAB1, WDFY1/VEGF-C), and interacts with non-transcriptional partners (PARP1, PARP1, Runx2, SNURF/RNF4) to exert cell-type-specific pro- or anti-apoptotic effects.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"HES1 is a bHLH transcriptional repressor that functions as a central effector of Notch signaling to maintain progenitor and stem cell identity across neural, hematopoietic, endocrine, and muscle lineages by repressing proneural genes (Ascl1/Mash1) and cell cycle inhibitors (p27Kip1, p57, p21) [PMID:7909512, PMID:15870295, PMID:16899237, PMID:10615124]. HES1 recruits Groucho/TLE corepressors whose chromatin association is enhanced by CK2-mediated hyperphosphorylation, and it also represses transcription at the elongation step by blocking P-TEFb recruitment to target genes such as CXCL1 [PMID:11756536, PMID:27322654]. HES1 expression oscillates with an approximately 2-hour period driven by a delayed negative autoregulatory feedback loop tuned by miR-9-mediated mRNA decay and Usp22/Usp27x-mediated protein stabilization, and the distinction between oscillatory versus sustained HES1 expression differentially controls proliferation versus quiescence through opposing effects on p21 via the Dusp7-ERK axis [PMID:12932324, PMID:23134481, PMID:25846153, PMID:37200191]. Beyond developmental contexts, HES1 directly represses immune and stress-response genes including CYLD, GADD34, VEGF-C/WDFY1, and GABAB1, and its protein stability is regulated by RASSF1A-SNURF/RNF4-mediated ubiquitin-dependent degradation [PMID:20832754, PMID:29491143, PMID:31015298, PMID:34897944].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Establishing HES1 as a neural differentiation repressor resolved the question of whether mammalian hairy/Enhancer-of-split homologs functionally inhibit neurogenesis, as shown by persistent HES1 expression blocking neuronal and glial differentiation in neural precursors.\",\n      \"evidence\": \"Retroviral HES1 transduction in mouse embryonic neural precursor cells in vivo and in vitro\",\n      \"pmids\": [\"7909512\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of repression (DNA binding vs. protein sequestration) not yet distinguished\", \"Identity of direct transcriptional targets unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Multi-tissue knockout analyses established HES1 as a general gatekeeper of progenitor cell differentiation across endoderm, retina, and CNS boundary regions, resolving whether its anti-differentiation function was neural-specific.\",\n      \"evidence\": \"Hes1-null and Hes1/Hes3 double-null mouse analyses in pancreas, gut, retina, and midbrain-hindbrain boundary; retroviral gain-of-function\",\n      \"pmids\": [\"10615124\", \"10839357\", \"11500373\", \"16728479\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets in each tissue not yet identified\", \"Relationship between HES1 and cell cycle exit mechanisms unresolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Domain dissection revealed that HES1 possesses two independent repression mechanisms — the WRPW/Groucho-dependent pathway and a helix 3/4 domain-dependent DNA-binding-dependent pathway — answering how HES1 could repress diverse targets including p21.\",\n      \"evidence\": \"Tetracycline-inducible HES1 domain mutants in PC12 cells with reporter assays and BrdU incorporation\",\n      \"pmids\": [\"10913198\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the helix 3/4 domain corepressor unknown\", \"How the two repression modes are coordinated in vivo unresolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Discovery that HES1 interaction with Groucho/TLE triggers CK2-mediated TLE hyperphosphorylation and chromatin association provided the first mechanistic link between HES1 binding and corepressor activation.\",\n      \"evidence\": \"Co-immunoprecipitation, in vitro CK2 kinase assay, chromatin fractionation, and pharmacological CK2 inhibition\",\n      \"pmids\": [\"11756536\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CK2 phosphorylation is required in vivo not tested\", \"How target specificity is achieved through TLE unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Mathematical modeling demonstrated that HES1's ~2-hour expression oscillations arise from delayed negative autoregulatory feedback without additional pathway components, framing HES1 as a biological clock.\",\n      \"evidence\": \"Delay differential equation modeling fitted to experimental Hes1 mRNA/protein dynamics\",\n      \"pmids\": [\"12932324\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Model not yet validated by perturbation of delay parameters in cells\", \"Post-transcriptional regulators of oscillation period not identified\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identification of p27Kip1 and subsequently p57 as direct HES1 targets via class C site binding resolved how HES1 couples transcriptional repression to cell cycle control in progenitors.\",\n      \"evidence\": \"ChIP and reporter assays for p27Kip1 and p57 promoters; Hes1-KO and Hes1/p57-double-KO mouse phenotypes\",\n      \"pmids\": [\"15870295\", \"16899237\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HES1 represses all CKIs simultaneously or selectively in different tissues unclear\", \"Chromatin state at CKI promoters under HES1 control not characterized\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Discovery that Id proteins physically interact with HES1 to release its autorepression without blocking its other targets explained how neural stem cells sustain high HES1 levels while maintaining its repressive activity on differentiation genes.\",\n      \"evidence\": \"Co-immunoprecipitation; Id overexpression in chick hindbrain; Id1/Id3 double-KO mouse with precocious neurogenesis\",\n      \"pmids\": [\"17681138\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of Id–HES1 interaction not resolved\", \"Whether Id–HES1 modulation occurs in non-neural tissues unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Linking HES1 to NF-κB pathway maintenance in T-ALL through direct CYLD repression revealed a non-developmental oncogenic function, answering how Notch sustains IKK activation in leukemia.\",\n      \"evidence\": \"ChIP for HES1 at CYLD locus; CYLD re-expression rescue; T-ALL cell lines and animal models\",\n      \"pmids\": [\"20832754\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CYLD repression by HES1 operates in normal T cells unknown\", \"Additional immune targets of HES1 not yet surveyed genome-wide\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstration that miR-9 targets the HES1 3′-UTR and is required for Hes1 oscillations in neural stem cells established a post-transcriptional layer essential for the HES1 oscillatory clock.\",\n      \"evidence\": \"Luciferase 3′-UTR reporter; miR-9 knockdown blocking oscillations and neuronal differentiation in mouse brain\",\n      \"pmids\": [\"23134481\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other miRNAs contribute to HES1 oscillation tuning not tested\", \"How miR-9 itself oscillates relative to HES1 not fully resolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identification of Usp22, Usp27x, and Usp51 as deubiquitinases that stabilize HES1 protein revealed the ubiquitin-dependent turnover mechanism governing oscillation period and amplitude.\",\n      \"evidence\": \"MS-based interactome from mouse ES cells; in vitro deubiquitination assays; cycloheximide chase; in vivo knockdown in developing brain\",\n      \"pmids\": [\"25846153\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the E3 ubiquitin ligase(s) for HES1 turnover not yet defined at this point\", \"Whether DUB activity itself oscillates unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Discovery that HES1 represses inflammatory genes by blocking P-TEFb recruitment and RNA Pol II Ser2 phosphorylation established a post-initiation repression mechanism distinct from classical promoter silencing.\",\n      \"evidence\": \"ChIP for P-TEFb and Pol II Ser2P at CXCL1 locus in Hes1 conditional KO macrophages; inflammatory arthritis model\",\n      \"pmids\": [\"27322654\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether elongation block is the primary mechanism at all HES1 targets unknown\", \"Structural basis of P-TEFb exclusion by HES1 not resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Live imaging in adult neural and muscle stem cells demonstrated that oscillatory versus sustained HES1 expression differentially controls quiescence vs. differentiation, reframing HES1 dynamics as a fate-determining signal rather than a simple on/off switch.\",\n      \"evidence\": \"Live-cell Hes1/Ascl1/MyoD reporters; conditional Hes1 KO in adult NSCs and muscle stem cells; compound Hes1/3/5 knockouts\",\n      \"pmids\": [\"30862661\", \"30862660\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How oscillation amplitude is sensed by downstream targets mechanistically unclear\", \"Whether oscillation dynamics differ between tissue stem cell types not systematically compared\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of RASSF1A as a scaffold for SNURF/RNF4-mediated HES1 ubiquitination and degradation provided the missing E3 ligase pathway controlling HES1 protein turnover and explained how the Notch-HES1 axis can be uncoupled independently of Hippo.\",\n      \"evidence\": \"Co-immunoprecipitation of RASSF1A, SNURF/RNF4, and HES1; ubiquitination assays; proteasome inhibitor experiments\",\n      \"pmids\": [\"34897944\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SNURF/RNF4 is the sole E3 for HES1 or acts redundantly with others unclear\", \"In vivo significance in stem cell oscillation context not tested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Resolving the paradox of how oscillatory HES1 promotes proliferation while sustained HES1 induces quiescence, this study showed sustained HES1 represses Dusp7, elevating p-ERK which induces p21 — the opposite of oscillatory HES1's direct p21 repression — establishing dynamics-dependent pathway switching.\",\n      \"evidence\": \"Conditional oscillatory vs. sustained Hes1 expression in mouse NSCs; Dusp7 and p-ERK analysis; p21 reporter assays\",\n      \"pmids\": [\"37200191\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Dusp7-ERK switching operates in non-neural stem cells unknown\", \"How transcriptional dynamics are decoded at the chromatin level remains unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include the structural basis for HES1's dual repression mechanisms (promoter silencing vs. elongation block), the full genome-wide catalog of direct targets across tissues, and how oscillation dynamics are decoded by downstream chromatin and signaling networks to produce binary fate outcomes.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal structure of HES1 in complex with corepressors or DNA\", \"Systematic comparison of HES1 oscillation parameters across tissue stem cell types lacking\", \"How HES1 dynamics-dependent pathway switching (e.g., Dusp7-ERK vs. direct p21 repression) is specified at the molecular level remains unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 6, 9, 11, 13, 18, 25, 28, 30, 31, 38, 39, 40]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [6, 11, 13, 20, 21, 25, 28, 31, 34, 38]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 6, 8, 11, 28, 34]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0074160\", \"supporting_discovery_ids\": [0, 6, 9, 11, 13, 25, 28, 30, 31, 34, 38, 40]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 18, 19, 37]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 3, 5, 7, 12, 32, 33, 35]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [11, 13, 15, 20, 40]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [2, 28, 34]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [22, 25, 31]}\n    ],\n    \"complexes\": [\n      \"HES1–Groucho/TLE corepressor complex\"\n    ],\n    \"partners\": [\n      \"TLE1\",\n      \"PARP1\",\n      \"RUNX2\",\n      \"USP22\",\n      \"USP27X\",\n      \"RNF4\",\n      \"RASSF1A\",\n      \"ID1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}